Skip to content

    Recently Viewed

      Listening...

      JNJ-Earns-Spot-on-Fortunes-2021-Change-the-World-List-lede-B.jpg

      Johnson & Johnson earns a spot on Fortune‘s 2021 Change the World list.

      The company is honored to be recognized for its part in helping battle the COVID-19 pandemic.

      Share Article
      share to

      This week Fortune included Johnson & Johnson on its 2021 Change the World list, which spotlights companies across the globe that have leveraged their core business strategies to drive positive social impact.

      While the vaccine makers on last year’s list were recognized for their unprecedented collaboration on fighting the coronavirus, this year’s list highlights those that are helping expand access to COVID-19 vaccines around the world. Johnson & Johnson is honored to be included for its efforts to make available its Janssen COVID-19 vaccine, for which it received Emergency Use Authorization from the U.S. Food and Drug Administration in February.

      To compile the prestigious list, Fortune evaluated companies on the impact they’ve made in addressing one or more of society’s problems, the business results of those actions and the level of innovation involved. Also taken into consideration: how essential the company’s initiative was to its overall business strategy.

      A Commitment to Social Responsibility and Innovation

      For more than a century, Johnson & Johnson has relied on a core set of values to guide every aspect of the way it does business.

      When COVID-19 hit, the company was able to respond to the once-in-a-lifetime global health challenge by harnessing its capabilities, scientific expertise, global partnerships and experience in helping fight pandemics for over a century—and its 130,000-plus employees around the world mobilized with urgency to address the critical needs of families, communities and healthcare providers.

      That sort of innovation and a commitment to social responsibility provide the foundation for Our Credo, the company mission statement that compels everyone who works at Johnson & Johnson to put the needs and well-being of people who depend on its products and services first.

      This isn’t the first time Fortune has recognized Johnson & Johnson. Earlier this month, Jennifer Taubert, the company’s Executive Vice President and Worldwide Chairman, Pharmaceuticals, was named to Fortune’s 2021 list of the Most Powerful Women in Business for the sixth consecutive year. In June, the company landed the #4 spot on Fortune’s Return on Leadership List, a ranking of the top 100 companies on the Fortune 500 list. And early this year, the brand included Johnson & Johnson among the World’s Most Admired Companies, placing it at #1 in the Pharmaceutical category worldwide for the eighth consecutive year.

      Johnson & Johnson is proud to be recognized again.

      More from Johnson & Johnson

      Innovation
      Blue latex-gloved hands holding a beaker filled with yellow liquid
      Innovation

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      Innovation
      DNA illustration genetic material
      Innovation

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      You are now leaving JNJ.com and going to a site with a different privacy policy. Please click below to continue to that site.